【レポートの概要（一部）】
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Prostate Cancer Market, By Type
5.1 Introduction
5.2 Hormone Sensitive
5.3 Hormone Refractory
6 Global Prostate Cancer Market, By Therapy
6.1 Introduction
6.2 Focal Therapies
6.3 Biologic Therapy
6.4 Cryosurgery
6.5 Immunotherapy
6.5.1 Vaccines
6.6 Therapeutic Vaccines
6.6.1 Provenge (Sipuleucel-T)
6.7 Radiation Therapy
6.7.1 External Beam
6.7.1.1 Stereotactic Body
6.7.1.2 Proton Beam
6.7.1.3 Intensity Modulated
6.7.1.4 3D Conformal
6.7.2 Brachytherapy
6.7.2.1 Temporary
6.7.2.2 Permanent
6.8 Chemotherapy
6.8.1 Vinorelbine
6.8.2 Vinblastine
6.8.3 Taxotere (Docetaxel)
6.8.4 Taxanes
6.8.5 Jevtana (Cabazitaxel)
6.8.6 Etoposide
6.8.7 Cytotoxic Drugs
6.8.8 Carboplatin
6.8.9 Antimetabolites
6.8.10 Anthracyclines
6.8.11 Alkylating Agents
6.9 Surgery
6.9.1 Trans Urethral Resection (TUR)
6.9.2 Radical Prostatectomy
6.9.3 Orchidectomy
6.10 Targeted Therapy
6.10.1 Tyrosine Kinase Inhibitors
6.10.2 Signal Transduction Inhibitor
6.10.3 Monoclonal Antibodies
6.10.4 Apoptosis Inducing Drugs
6.10.5 Angiogenesis Inhibitor
6.11 Bone Metastasis
6.11.1 Zometa (Zoledronic Acid)
6.11.2 Xofigo (Radium 223 Dichloride)
6.11.3 Xgeva (Denosumab)
6.11.4 Alpharadin
6.12 Hormonal Therapy
6.12.1 Aromatase Inhibitors
6.12.2 Estrogen-Receptor Modulators (Serms)
6.12.3 Luteinizing Hormone–Releasing Hormone (LHRH) Analogs
6.12.3.1 Lupron
6.12.3.2 Zoladex
6.12.3.3 Decapeptyl
6.12.3.4 Eligard
6.12.3.5 Vantas
6.12.3.6 Leuplin
6.12.3.7 Trelstar (Triptorelin Pamoate)
6.12.3.8 Firmagon (Degarelix)
6.12.3.9 Casodex (Bicalutamide)
6.12.4 Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists
6.12.4.1 Zytiga
6.12.4.2 Gonax
6.12.4.3 Xtandi (Enzalutamide)
6.12.5 Anti–Androgens
6.12.5.1 Casodex
6.12.5.2 Xtandi or MDV3100
6.12.5.3 Xtandi US or MDV3100
6.12.6 Other Hormonal Therapies
7 Global Prostate Cancer Market, By Diagnostic Technique
7.1 Introduction
7.2 Prostate Specific Antigen Test (PSA)
7.3 Digital Rectal Exam (DRE)
8 Global Prostate Cancer Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Hospitals
8.4 Pharmacies
8.5 Specialty Clinics
8.6 Other End Users
9 Global Prostate Cancer Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Astellas, Inc.
11.2 AstraZeneca plc
11.3 Bristol Myers Squibb (BMS)
11.4 Johnson & Johnson
11.5 NOVARTIS
11.6 Sanofi S.A
11.7 TOLMAR Inc.
11.8 Tokai Pharmaceuticals
11.9 Progenics Pharmaceuticals Inc.
11.10 OncoGenex Pharmaceuticals Inc.
11.11 OncBioMune Pharmaceuticals Inc.
11.12 Endo Pharmaceuticals
11.13 Bayer Pharma AG
List of Tables
Table 1 Global Prostate Cancer Market Outlook, By Region (2016-2026) (US $MN)
Table 2 Global Prostate Cancer Market Outlook, By Type (2016-2026) (US $MN)
Table 3 Global Prostate Cancer Market Outlook, By Hormone Sensitive (2016-2026) (US $MN)
Table 4 Global Prostate Cancer Market Outlook, By Hormone Refractory (2016-2026) (US $MN)
Table 5 Global Prostate Cancer Market Outlook, By Therapy (2016-2026) (US $MN)
Table 6 Global Prostate Cancer Market Outlook, By Focal Therapies (2016-2026) (US $MN)
Table 7 Global Prostate Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
Table 8 Global Prostate Cancer Market Outlook, By Cryosurgery (2016-2026) (US $MN)
Table 9 Global Prostate Cancer Market Outlook, By Immunotherapy (2016-2026) (US $MN)
Table 10 Global Prostate Cancer Market Outlook, By Vaccines (2016-2026) (US $MN)
Table 11 Global Prostate Cancer Market Outlook, By Therapeutic Vaccines (2016-2026) (US $MN)
Table 12 Global Prostate Cancer Market Outlook, By Provenge (Sipuleucel-T) (2016-2026) (US $MN)
Table 13 Global Prostate Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
Table 14 Global Prostate Cancer Market Outlook, By External Beam (2016-2026) (US $MN)
Table 15 Global Prostate Cancer Market Outlook, By Brachytherapy (2016-2026) (US $MN)
Table 16 Global Prostate Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
Table 17 Global Prostate Cancer Market Outlook, By Vinorelbine (2016-2026) (US $MN)
Table 18 Global Prostate Cancer Market Outlook, By Vinblastine (2016-2026) (US $MN)
Table 19 Global Prostate Cancer Market Outlook, By Taxotere (Docetaxel) (2016-2026) (US $MN)
Table 20 Global Prostate Cancer Market Outlook, By Taxanes (2016-2026) (US $MN)
Table 21 Global Prostate Cancer Market Outlook, By Jevtana (Cabazitaxel) (2016-2026) (US $MN)
Table 22 Global Prostate Cancer Market Outlook, By Etoposide (2016-2026) (US $MN)
Table 23 Global Prostate Cancer Market Outlook, By Cytotoxic Drugs (2016-2026) (US $MN)
Table 24 Global Prostate Cancer Market Outlook, By Carboplatin (2016-2026) (US $MN)
Table 25 Global Prostate Cancer Market Outlook, By Antimetabolites (2016-2026) (US $MN)
Table 26 Global Prostate Cancer Market Outlook, By Anthracyclines (2016-2026) (US $MN)
Table 27 Global Prostate Cancer Market Outlook, By Alkylating Agents (2016-2026) (US $MN)
Table 28 Global Prostate Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
Table 29 Global Prostate Cancer Market Outlook, By Trans Urethral Resection (TUR) (2016-2026) (US $MN)
Table 30 Global Prostate Cancer Market Outlook, By Radical Prostatectomy (2016-2026) (US $MN)
Table 31 Global Prostate Cancer Market Outlook, By Orchidectomy (2016-2026) (US $MN)
Table 32 Global Prostate Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
Table 33 Global Prostate Cancer Market Outlook, By Tyrosine Kinase Inhibitors (2016-2026) (US $MN)
Table 34 Global Prostate Cancer Market Outlook, By Signal Transduction Inhibitor (2016-2026) (US $MN)
Table 35 Global Prostate Cancer Market Outlook, By Monoclonal Antibodies (2016-2026) (US $MN)
Table 36 Global Prostate Cancer Market Outlook, By Apoptosis Inducing Drugs (2016-2026) (US $MN)
Table 37 Global Prostate Cancer Market Outlook, By Angiogenesis Inhibitor (2016-2026) (US $MN)
Table 38 Global Prostate Cancer Market Outlook, By Bone Metastasis (2016-2026) (US $MN)
Table 39 Global Prostate Cancer Market Outlook, By Zometa (Zoledronic Acid) (2016-2026) (US $MN)
Table 40 Global Prostate Cancer Market Outlook, By Xofigo (Radium 223 Dichloride) (2016-2026) (US $MN)
Table 41 Global Prostate Cancer Market Outlook, By Xgeva (Denosumab) (2016-2026) (US $MN)
Table 42 Global Prostate Cancer Market Outlook, By Alpharadin (2016-2026) (US $MN)
Table 43 Global Prostate Cancer Market Outlook, By Hormonal Therapy (2016-2026) (US $MN)
Table 44 Global Prostate Cancer Market Outlook, By Aromatase Inhibitors (2016-2026) (US $MN)
Table 45 Global Prostate Cancer Market Outlook, By Estrogen-Receptor Modulators (Serms) (2016-2026) (US $MN)
Table 46 Global Prostate Cancer Market Outlook, By Luteinizing Hormone–Releasing Hormone (LHRH) Analogs (2016-2026) (US $MN)
Table 47 Global Prostate Cancer Market Outlook, By Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists (2016-2026) (US $MN)
Table 48 Global Prostate Cancer Market Outlook, By Anti–Androgens (2016-2026) (US $MN)
Table 49 Global Prostate Cancer Market Outlook, By Other Hormonal Therapies (2016-2026) (US $MN)
Table 50 Global Prostate Cancer Market Outlook, By Diagnostic Technique (2016-2026) (US $MN)
Table 51 Global Prostate Cancer Market Outlook, By Prostate Specific Antigen Test (PSA) (2016-2026) (US $MN)
Table 52 Global Prostate Cancer Market Outlook, By Digital Rectal Exam (DRE) (2016-2026) (US $MN)
Table 53 Global Prostate Cancer Market Outlook, By End User (2016-2026) (US $MN)
Table 54 Global Prostate Cancer Market Outlook, By Ambulatory Surgical Centers (2016-2026) (US $MN)
Table 55 Global Prostate Cancer Market Outlook, By Hospitals (2016-2026) (US $MN)
Table 56 Global Prostate Cancer Market Outlook, By Pharmacies (2016-2026) (US $MN)
Table 57 Global Prostate Cancer Market Outlook, By Specialty Clinics (2016-2026) (US $MN)
Table 58 Global Prostate Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.
【レポート販売概要】
■ タイトル：前立腺がんの世界市場展望2017-20276■ 英文：Prostate Cancer - Global Market Outlook (2017-2026)
■ 発行日：2019年8月
■ 調査会社：Stratistics MRC
■ 商品コード：SMRC20FB306
■ 調査対象地域：グローバル
- 世界の点眼薬市場：データ、分析、予測（～2024）Which ophthalmic drugs lead the market in 2013? Will the same drugs be as successful in 2018? How will this landscape change across the next 10 years? Which trial drugs are likely to make an impact? Only one report will tell you the answers. Simply by ordering and reading GMR Data’s new ‘Ophthalmic Drugs; Data, Analysis and Forecasts to 2024’ report, you can stay ahead of your competition. It real …
- エレベーター・エスカレーターの世界市場2016-2020About Elevator and Escalator Elevators and escalators are installed in commercial, residential, and mixed-used buildings; IT parks; hotels and restaurants; and retail outlets. The global elevator and escalator market is likely to be driven by the growth of the global construction market. The global construction market is experiencing significant growth, especially in the emerging economies such as …
- 世界の医療用サイクロトロン市場：製品別、地域別Global Medical Cyclotron Market: About this market Technavio’s medical cyclotron market analysis considers sales from cyclotron 35 MeV products. Our study also finds the sales of medical cyclotron in Asia, Europe, North America, and ROW. In 2019, the cyclotron
- Double Eagle Petroleum Co.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Double Eagle Petroleum Co. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Double Eagle Petroleum Co. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
- 末梢血管装置（医療機器）のグローバル市場（2012-2018）Global Peripheral Vascular Devices sector forecasts to reach US$5 billion by 2016 at a CAGR of 10.8% during the analysis period 2012-2018. North American region accounts for highest percentage approximately 42% (2015) of global share while Europe follows next with nearly 27.7% (2018) of the market. Asia-Pacific is the fastest growing region with a CAGR of 12.5% driving a market value of US$1 billi …
- 自動車用オイルフィルター/燃料フィルターの世界市場The global automotive oil and fuel filter market size, in terms of value, is estimated to grow at a CAGR of 6.64% for the period 2015 to 2020. The market is driven by factors such as the rising demand for vehicles in the BRICS nations, growing environmental concerns regarding emissions, and increased adoption of personal vehicles for daily commute. In this report, the global automotive oil and fue …
- 痔疾(Hemorrhoids)：世界の治験レビュー（2015年上半期版）Hemorrhoids Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hemorrhoids Global Clinical Trials Review, H1, 2015" provides data on the Hemorrhoids clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemorrhoids. It includes an overview of the trial numbers and their recruitment status as per the site of …
- 免税店小売の世界市場2015-2019Technavios research analyst predicts the global duty-free retailing market to grow steadily at a CAGR of around 9% during the forecast period. The increase in international travelers is the primary driver for the growth of this market. The number of foreign travelers during 2014 was around 1 billion, with Europe emerging as the most popular destination. However, the restrictions on the baggage wei …
- オーガニックスパイスの世界市場：製品種類別（ジンジャー、ウコン、クローブ、コショウ、シナモン、ナツメグ、マスタードシード、その他）、フォーム別（粉末、粒状、抽出物、生）、流通チャンネル別（直接、間接）The global organic spices market was valued at $272.8 million in 2018 and is projected to reach $406.6 million by 2026, growing at a CAGR of 5.1% from 2019 to 2026. . Chinese and Thai cuisines have been gaining popularity in some of the major countries around the globe. These cuisines are being prepared using spices, which act as coloring or flavoring agent. On the other hand, the demand for organ …
- 次亜リン酸ナトリウムの世界市場予測（～2025年）“The sodium hypophosphite market is projected to grow at a CAGR of 5.0%, in terms of value.”The global sodium hypophosphite market is estimated to be valued at USD 664 million in 2019 and is likely to reach USD 890 million by 2025, growing at a CAGR of 5.0% during the forecast period. The Asia Pacific region, backed by the development of its electronics and automotive industry, holds high growth p …
- X線検出器の世界市場：フラットパネル検出器、CR検出器、CCD検出器、ラインスキャン検出器The global X-ray detectors market, in terms of value, is projected to reach USD 2.89 Billion by 2021 from USD 2.21 Billion in 2016, at a CAGR of 5.5% during the forecast period. This market is expected to grow faster in terms of volume (no. of units) than value. Growth in this market is mainly driven by technological advancements, growing adoption of FPDs (flat-panel detectors), growing geriatric …
- 世界の肺炎検査市場The report presents a detailed analysis of the Pneumonia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- TransAtlantic Petroleum Ltd.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013TransAtlantic Petroleum Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary TransAtlantic Petroleum Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
- EnCana Corporation社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）EnCana Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary EnCana Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- Yoho Resources Inc.：石油・ガスバリューチェーン分析レポート2013Yoho Resources Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Yoho Resources Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Yoho Resources Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
